222 related articles for article (PubMed ID: 33465053)
1. CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
Lewinsky H; Gunes EG; David K; Radomir L; Kramer MP; Pellegrino B; Perpinial M; Chen J; He TF; Mansour AG; Teng KY; Bhattacharya S; Caserta E; Troadec E; Lee P; Feng M; Keats J; Krishnan A; Rosenzweig M; Yu J; Caligiuri MA; Cohen Y; Shevetz O; Becker-Herman S; Pichiorri F; Rosen S; Shachar I
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33465053
[TBL] [Abstract][Full Text] [Related]
2. CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.
Lewinsky H; Barak AF; Huber V; Kramer MP; Radomir L; Sever L; Orr I; Mirkin V; Dezorella N; Shapiro M; Cohen Y; Shvidel L; Seiffert M; Herishanu Y; Becker-Herman S; Shachar I
J Clin Invest; 2018 Dec; 128(12):5465-5478. PubMed ID: 30277471
[TBL] [Abstract][Full Text] [Related]
3. CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis.
Zheng N; Fleming J; Hu P; Jiao J; Zhang G; Yang R; Li C; Liu Y; Bi L; Zhang H
Microbiol Spectr; 2022 Feb; 10(1):e0155721. PubMed ID: 35196822
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner.
Barak AF; Lewinsky H; Perpinial M; Huber V; Radomir L; Kramer MP; Sever L; Wolf Y; Shapiro M; Herishanu Y; Jung S; Becker-Herman S; Shachar I
Oncogene; 2020 Feb; 39(9):1997-2008. PubMed ID: 31772329
[TBL] [Abstract][Full Text] [Related]
5. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Alban TJ; Bayik D; Otvos B; Rabljenovic A; Leng L; Jia-Shiun L; Roversi G; Lauko A; Momin AA; Mohammadi AM; Peereboom DM; Ahluwalia MS; Matsuda K; Yun K; Bucala R; Vogelbaum MA; Lathia JD
Front Immunol; 2020; 11():1191. PubMed ID: 32625208
[TBL] [Abstract][Full Text] [Related]
7. CD84 mediates CLL-microenvironment interactions.
Marom A; Barak AF; Kramer MP; Lewinsky H; Binsky-Ehrenreich I; Cohen S; Tsitsou-Kampeli A; Kalchenko V; Kuznetsov Y; Mirkin V; Dezorella N; Shapiro M; Schwartzberg PL; Cohen Y; Shvidel L; Haran M; Becker-Herman S; Herishanu Y; Shachar I
Oncogene; 2017 Feb; 36(5):628-638. PubMed ID: 27452524
[TBL] [Abstract][Full Text] [Related]
8. Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.
Lim JY; Kim TW; Ryu DB; Park SS; Lee SE; Kim BS; Min CK
Cancer Immunol Res; 2021 May; 9(5):503-513. PubMed ID: 33771821
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
[TBL] [Abstract][Full Text] [Related]
10. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
Agresta L; Lehn M; Lampe K; Cantrell R; Hennies C; Szabo S; Wise-Draper T; Conforti L; Hoebe K; Janssen EM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217758
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
[TBL] [Abstract][Full Text] [Related]
12. CD84 is a survival receptor for CLL cells.
Binsky-Ehrenreich I; Marom A; Sobotta MC; Shvidel L; Berrebi A; Hazan-Halevy I; Kay S; Aloshin A; Sagi I; Goldenberg DM; Leng L; Bucala R; Herishanu Y; Haran M; Shachar I
Oncogene; 2014 Feb; 33(8):1006-16. PubMed ID: 23435417
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Agresta L; Hoebe KHN; Janssen EM
Front Immunol; 2018; 9():2809. PubMed ID: 30546369
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.
Kuwahara-Ota S; Shimura Y; Steinebach C; Isa R; Yamaguchi J; Nishiyama D; Fujibayashi Y; Takimoto-Shimomura T; Mizuno Y; Matsumura-Kimoto Y; Tsukamoto T; Chinen Y; Kobayashi T; Horiike S; Taniwaki M; Gütschow M; Kuroda J
Br J Haematol; 2020 Dec; 191(5):784-795. PubMed ID: 32558939
[TBL] [Abstract][Full Text] [Related]
16. CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.
Cuenca M; Sintes J; Lányi Á; Engel P
Clin Immunol; 2019 Jul; 204():43-49. PubMed ID: 30522694
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.
Ferrer G; Jung B; Chiu PY; Aslam R; Palacios F; Mazzarello AN; Vergani S; Bagnara D; Chen SS; Yancopoulos S; Xochelli A; Yan XJ; Burger JA; Barrientos JC; Kolitz JE; Allen SL; Stamatopoulos K; Rai KR; Sherry B; Chiorazzi N
Leukemia; 2021 Nov; 35(11):3163-3175. PubMed ID: 33935280
[TBL] [Abstract][Full Text] [Related]
18. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
[TBL] [Abstract][Full Text] [Related]
19. CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute Stroke.
Schuhmann MK; Stoll G; Bieber M; Vögtle T; Hofmann S; Klaus V; Kraft P; Seyhan M; Kollikowski AM; Papp L; Heuschmann PU; Pham M; Nieswandt B; Stegner D
Circ Res; 2020 Sep; 127(8):1023-1035. PubMed ID: 32762491
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
Podar K; Jager D
Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
